The combined effect of high energy shock waves (HESW), generated by a piezoelectric device, and paclitaxel on Mat B-III rat breast cancer cells in vitro and in an in vivo animal model is presented. A significant reduction of in vitro Mat B-III cell proliferation versus cells treated with paclitaxel alone was observed with the combined exposure to paclitaxel (0.1, 1, or 10 nM) and HESW (0.22 mJ/mm2, 1000 shots). Moreover earlier induction and enhanced apoptosis occurred in cells subjected to the combined treatment with paclitaxel and HESW at 1 and 10 nM versus paclitaxel alone (p<0.01 and p<0.001, respectively).
The percentage of apoptotic cells along with BAD mRNA expression, confirm a significant enhancement of apoptosis in tumor tissues subjected to the combined treatment with paclitaxel (2.5 mg/kg on days 7 and 11) and HESW (0.50 mJ/mm2, 500 shots on day 11) in comparison with paclitaxel alone. In conclusion, these data suggest that HESW enhance paclitaxel cytotoxicity in the Mat B-III syngeneic model of breast cancer.
DeliusM.Medical applications and biological effects of extracorporeal shock waves. Shock Waves4, 55–72 (1994).
2.
SchlebergerR.DeliusM.DahmenG. P.DieschR.SchadenW.ThieleR.VogelJ.Orthopaedic Extracorporeal Shock Wave Therapy (ESWT). Method Analysis and Suggestion of a Prospective Study Design — Consensus Report, in High Energy Shock Waves in Medicine, pp. 108–111. Eds., ChaussyC.EisenbergerF.JochamD.WilbertD., Stuttgart, George Thieme Verlag (1997).
3.
RandazzoR. F.ChaussyG. C.FuchsG. J.BhutaS.M.LovrekovichH.de KernionJ. B.The in vitro and in vivo effects of extracorporeal shock waves on malignant cells. Urol Res16, 419–426 (1988).
4.
GambihlerS.DeliusM.BrendelW.Biological effects of shock waves: Cell disruption, viability, and proliferation of L1210 cells exposed to shock wavesin vitro. Ultrasound Med Biol16, 587–593 (1990).
5.
GamarraF.SpelsbergF.DellianM.GoetzA. E.Complete local tumor remission after therapy with extra-corporeally applied high-energy shock waves (HESW). Int J Cancer55, 153–156 (1993).
6.
HuberP. E.DebusJ.Tumor cytotoxicity in vivo and radical formation in vitro depend on the shock wave-induced cavitation dose. Radiat Res156, 301–309 (2001).
7.
OosterhofG. O. N.SmitsG. A. H. J.de RuyterJ. E.van MoorselarR. J. A.SchalkenJ. A.DebruyneF. M. J.The in vitro effect of electromagnetically generated shock waves (Lithostar) on the Dunning R3327 PAT-2 rat prostatic cancer cell-line. A potentiating effect on the in vitro cytotoxicity of vinblastin. Urol Res17, 13–19 (1989).
8.
ClaymanR. V.LongS.MarcusM.High energy shock waves: in vitro effects. Am J Kidney Dis17, 436–444 (1991).
9.
JonesB. J.McHaleA. P.ButlerM. R.Effect of high-energy shock wave frequency on viability of malignant cell linesin vitro. Eur Urol22, 70–73 (1992).
10.
YaoC. Z.IshizukaJ.BoldR. J.TownsendC. M.Jr.ThompsonJ. C.Cytocidal effect of high energy shock wave on tumor cells enhanced with larger dose and multiple exposures. Surg Oncol3, 229–235 (1994).
11.
RoesslerW.RothgangelB.HofstaedterF.WielandW.F.Treatment of human renal cell carcinoma with high-energy shock waves: A new in vivo/in vitro model. Urol Intern55, 1–5 (1995).
12.
GambihlerS.DeliusM.In vitro effects of lithotripter shock waves and cytotoxic drugs. Br J Cancer66, 69–73 (1992).
13.
WörleK.SteinbachP.HofstädterF.The combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cells. Br J Cancer69, 58–65 (1994).
14.
PratF.SibilleA.LuccioniC.PansuD.ChapelonJ. Y.BeaumatinJ.PonchonT.CathignolD.Increased chemocytotoxicity to colon cancer cells by shock wave-induced cavitation. Gastroenterology106, 937–944 (1994).
15.
KambeM.IoritaniN.KanamaruR.Enhancement of chemotherapeutic effects with focused shock waves: Extracorporeal shock wave chemotherapy (ESWC). Hum Cell10, 87–94 (1997).
16.
KatoM.IoritaniN.SuzukiT.KambeM.InabaY.WatanabeR.SasanoH.OrikasaS.Mechanism of anti-tumor effect of combination of bleomycin and shock waves. Jpn J Cancer Res91, 1065–1072 (2000).
17.
PerezE. A.Paclitaxel in breast cancer. Oncologist3, 373–389 (1998).
18.
WangL. G.LiuX. M.KreisW.BudmanD. R.The effect of antimicrotubule agents on signal transduction pathways of apoptosis: A review. Cancer Chemother Pharmacol44, 355–361 (1999).
19.
FrairiaR.CatalanoM. G.FortunatiN.FazzariA.RaineriM.BertaL.High energy shock waves (HESW) enhance paclitaxel cytotoxicity in MCF-7 cells. Breast Cancer Res Treat81, 11–19 (2003).
20.
FolberthW.KohlerG.RohwedderA.MaturaE.Pressure distribution and energy flow in the focal region of two different electromagnetic shock wave sources. J Stone Dis4, 1–7 (1992).
21.
WessO.UeberleF.DürßenR. N.HilckenD.KraußW.ReunerT.SchultheißR.StaudenrausI.RattnerM.HaaksW.GranzB.Working group technical developments — consensus report, in High Energy Shock Waves in Medicine. Clinical Application in Urology, Gastroenterology and Orthopedics, pp. 59–71. Eds., ChaussyC.EisenbergerF.JochamD.WilbertD., Stuttgart, Georg Thieme Verlag (1997).
22.
KernD. H.MorganC. R.Hildebrand-ZankiS. U.In vitro pharmacodynamics of 1-b-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II). Cancer Res48, 117–121 (1988).
23.
GambihlerS.DeliusM.In vitro effects of lithotripter shock waves and cytotoxic drugs. Br J Cancer66, 69–73 (1992).
24.
KambeM.IoritaniN.KanamaruR.Enhancement of chemotherapeutic effects with focused shock waves: Extracorporeal shock wave chemotherapy (ESWC). Hum Cell10, 87–94 (1997).
25.
BacusS. S.GudkovA. V.LoweM.LyassL.YungY.KomarovA. P.KeyomarsiK.YardenY.SegerR.Taxol-induced apoptosis depend on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene20, 147–155 (2001).
26.
CharlesA. G.HanT.-Y.LiuY. Y.HansenN.GiulianoA. E.CabotM. C.Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol47, 444–450 (2001).
27.
VermesI.HaanenC.Steffens-NakkenH.ReutelingspergerC.A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods184, 39–51 (1995).
28.
RosenthalI.SostaricJ. Z.RieszP.Sonodynamic therapy-a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem11, 349–363 (2004).
29.
CanaparoR.SerpeL.CatalanoM. G.BoscoO.ZaraG. P.BertaL.FrairiaR.High energy shock waves (HESW) for sonodynamic therapy: Effects on HT-29 human colon cancer cells. Anticancer Res26, 3337–3342 (2006).
30.
JordanM. A.TosoR. J.ThrowerD.WilsonL.Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA90, 9552–9556 (1993).
